Patent intelligence · US
US 9101565
Dissolution stability of calcium carbonate tablets
Dissolution stability of calcium carbonate tablets
Patent details — US 9101565
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 11, 2015
- Expiration
- Aug 6, 2035
- Applicant
- TAKEDA NYCOMED AS
- Claims
- 3
- CPC classes
- A61K, A61K33/06, A61K33/10, A61K9/2018
Quick answer
US 9101565 (Dissolution stability of calcium carbonate tablets) is held by TAKEDA NYCOMED AS. Status: granted. Granted Aug 11, 2015. Expires Aug 6, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TAKEDA NYCOMED AS
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K33/06, A61K33/10, A61K9/2018, A61K9/2072, A61K9/2095
More from TAKEDA NYCOMED AS
Related pharmaceutical patents in our USPTO index.
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted
Frequently asked questions
What is US patent 9101565?
US 9101565 (Dissolution stability of calcium carbonate tablets) is held by TAKEDA NYCOMED AS. Status: granted. Granted Aug 11, 2015. Expires Aug 6, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9101565?
TAKEDA NYCOMED AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1,436 pharmaceutical patents for this assignee.
When does US 9101565 expire?
Our index shows an expiration date of Aug 6, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.